Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.77 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.77 |
| ▸ | POLB | P06746 | 1/20 | 0.77 |
| ▸ | PKM | P14618 | 1/20 | 0.77 |
| ▸ | TSHR | P16473 | 2/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.67 |
| ▸ | MEN1 | O00255 | 3/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.66 |
| ▸ | DRD2 | P14416 | 2/20 | 0.66 |
| ▸ | DRD4 | P21917 | 2/20 | 0.66 |
| ▸ | GAA | P10253 | 1/20 | 0.66 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.66 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.66 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.66 |
| ▸ | MAPT | P10636 | 4/20 | 0.63 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | NPC1 | O15118 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20957047 | 0.87 | ALDH1A1 (0.62) | ALDH1A1KDM4EPOLBPKMTSHR | |
| SCHEMBL29538698 | 0.86 | ALDH1A1 (0.84) | ALDH1A1KDM4EPOLBPKMMEN1 | |
| SCHEMBL20957045 | 0.85 | MAPK1 (0.63) | ALDH1A1KDM4EPOLBPKMTSHR | |
| SCHEMBL22079937 | 0.81 | ALDH1A1 (0.76) | ALDH1A1KDM4EPOLBPKMMAPK1 | |
| SCHEMBL429291 | 0.80 | DRD2 (0.54) | ALDH1A1KDM4EPOLBPKMMEN1 | |
| SCHEMBL5626219 | 0.80 | ALDH1A1 (0.52) | ALDH1A1KDM4EPOLBPKMTSHR | |
| Hydrochloric Acid SCHEMBL29488453 | 0.80 | TSHR (0.69) | ALDH1A1POLBTSHRMAPK1MEN1 | |
| SCHEMBL20956993 | 0.80 | ALDH1A1 (1.00) | ALDH1A1KDM4EPOLBPKMTSHR | |
| SCHEMBL7657811 | 0.80 | DRD4 (1.00) | ALDH1A1MEN1KMT2ADRD2DRD4 | |
| Hydrochloric Acid SCHEMBL4221996 | 0.79 | ALDH1A1 (0.68) | ALDH1A1KDM4EPOLBPKMTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120131972-A | Microsatellite stabilized colorectal cancer combination therapy based on PCSK9 inhibitors | 广东省人民医院 | 2025-06-13 | — | — | CN | claimed |
| US-20260139573-A1 | POWER SYSTEM FOR DOWNHOLE TOOLSTRING | FASTCAP ULTRACAPACITORS LLC (US) | 2026-05-21 | — | — | US | disclosed |
| US-12529291-B2 | Power system for downhole toolstring | FASTCAP ULTRACAPACITORS LLC (US) | 2026-01-20 | — | — | US | disclosed |
| EP-4577306-A1 | COMBINATION CANCER TREATMENT COMPRISING AN ANTI-MSLN/CD137 ANTIBODY AND PD-1/PD-L1 INHIBITOR | Merck Patent GmbH (DE) | 2025-07-02 | — | — | EP | disclosed |
| EP-4578457-A1 | PHARMACEUTICAL FOR TREATING AND/OR PREVENTING CANCER | Toray Industries, Inc. (JP) | 2025-07-02 | — | — | EP | disclosed |
| CN-120131972-A | Microsatellite stabilized colorectal cancer combination therapy based on PCSK9 inhibitors | 广东省人民医院 | 2025-06-13 | — | — | CN | disclosed |
| US-12302784-B1 | Stand-on mower intermediate pulley system | BAD BOY MOWERS, LLC (US) | 2025-05-20 | — | — | US | disclosed |
| US-12284939-B1 | Stand-on mower folding platform system | BAD BOY MOWERS, LLC (US) | 2025-04-29 | — | — | US | disclosed |
| CN-119836302-A | Combination cancer treatment comprising anti-MSLN/CD 137 antibodies and PD-1/PD-L1 inhibitors | 默克专利股份公司 | 2025-04-15 | — | — | CN | disclosed |
| CN-119768182-A | Medicine for treating and/or preventing cancer | 东丽株式会社 | 2025-04-04 | — | — | CN | disclosed |
| CN-220457115-U | Microcomputer protection device | 四川电力智能配电设备有限公司 | 2024-02-06 | — | — | CN | disclosed |
| US-20230374888-A1 | POWER SYSTEM FOR DOWNHOLE TOOLSTRING | WINDSAIL CAPITAL FUND, L.P. | 2023-11-23 | — | — | US | disclosed |
| US-11697978-B2 | Power system for downhole toolstring | FASTCAP SYSTEMS CORPORATION (US) | 2023-07-11 | — | — | US | disclosed |
| CN-115515969-A | Application of FGF4 and Fgfr1 binding ligand in diabetes | 温州医科大学 | 2022-12-23 | — | — | CN | disclosed |
| US-20220378699-A1 | SELF-EMULSIFYING CANNABIS EXTRACT | IPT EDIBLES LTD. (IL) | 2022-12-01 | — | — | US | disclosed |
| CN-115175926-A | Activatable cytokine polypeptides and methods of use thereof | 狼人治疗公司 | 2022-10-11 | — | — | CN | disclosed |
| US-11432712-B2 | Fluorescence imaging scope with dual mode focusing structures | KARL STORZ IMAGING, INC. (US) | 2022-09-06 | — | — | US | disclosed |
| US-20220138586-A1 | MEMORY SYSTEM OF AN ARTIFICIAL NEURAL NETWORK BASED ON A DATA LOCALITY OF AN ARTIFICIAL NEURAL NETWORK | DEEPX CO., LTD. (KR) | 2022-05-05 | — | — | US | disclosed |
| CN-109068655-B | Pesticidal active mixtures of tioxazafen | 巴斯夫欧洲公司 | 2022-05-03 | — | — | CN | disclosed |
| CN-109198602-B | Compound ganoderma lucidum polysaccharide oral liquid and preparation method thereof | 开平健之源保健食品有限公司 | 2022-04-05 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12529291-B2 | Power system for downhole toolstring | ERCC1, MRE11, SCN2B | ALDH1A1 3921/4885KDM4E 2488/4885POLB 598/4885 |
| US-20260139573-A1 | POWER SYSTEM FOR DOWNHOLE TOOLSTRING | PARP2, PRKAG2, PRKAA2 | ALDH1A1 3919/4885KDM4E 3439/4885POLB 291/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.